BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8574164)

  • 1. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
    Chang H; Blondal JA; Benchimol S; Minden MD; Messner HA
    Leuk Lymphoma; 1995 Sep; 19(1-2):165-71. PubMed ID: 8574164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
    Williams ME; Frierson HF; Tabbarah S; Ennis PS
    Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
    Lee JT; Innes DJ; Williams ME
    J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic rearrangement of the c-myc proto-oncogene in non-AIDS-related lymphoma in Japan.
    Nagai M; Ikeda K; Tasaka T; Irino S
    Leukemia; 1991 Jun; 5(6):462-7. PubMed ID: 2056771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
    Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
    Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
    Kondo E; Yoshino T; Akagi T; Hayashi K; Takahashi K
    Acta Med Okayama; 1992 Dec; 46(6):407-15. PubMed ID: 1485535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of cutaneous B- and T-cell lymphomas.
    Neri A; Fracchiolla NS; Roscetti E; Garatti S; Trecca D; Boletini A; Perletti L; Baldini L; Maiolo AT; Berti E
    Blood; 1995 Oct; 86(8):3160-72. PubMed ID: 7579411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes.
    Farrugia MM; Duan LJ; Reis MD; Ngan BY; Berinstein NL
    Blood; 1994 Jan; 83(1):191-8. PubMed ID: 8274734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma.
    Chang H; Benchimol S; Minden MD; Messner HA
    Blood; 1994 Jan; 83(2):452-9. PubMed ID: 8286743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
    Butler M; Corbally N; Dervan PA; Carney DN
    Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
    Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
    Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
    Song W; Liu MG; Zhang JB; Zhang JJ; Sun MM; Yu QK
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1093-7. PubMed ID: 27049262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
    Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
    Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms.
    Yano T; Sander CA; Andrade RE; Gauwerky CE; Croce CM; Longo DL; Jaffe ES; Raffeld M
    Blood; 1993 Sep; 82(6):1813-9. PubMed ID: 8400234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2.
    Martinez-Valdez H; Guret C; de Bouteiller O; Fugier I; Banchereau J; Liu YJ
    J Exp Med; 1996 Mar; 183(3):971-7. PubMed ID: 8642300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.
    Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M
    Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
    Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.